Skip to main content

Table 1 Basic characteristics of participants

From: Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study

 

BMI < 23

BMI ≥ 23

P value

WC ≤ 90

WC > 90

P value

No

21

75

 

72

24

 

Age

61.25±9.80

61.48±7.09

0.982

60.58±7.60

64.20±7.54

0.045

PSA

2.12±

2.04±

0.231

2.13±

1.98±

0.312

PV

31.12±10.14

34.23±8.71

0.042

32.31±9.81

33.23±10.21

0.218

Qmax

12.32±2.21

13.25±1.75

0.134

11.46±1.89

13.33±2.34

0.185

IPSS questionnaire

Total IPSS

14.90±7.58

13.41±6.79

0.388

15.00±7.57

13.31±6.74

0.308

IPSS QoL

3.47±1.21

3.54±1.22

0.830

3.56±1.40

3.51±1.15

0.864

KHQ questionnaire

General health

41.66±18.25

47.66±23.67

0.286

47.91±26.49

45.83±21.39

0.698

Impact on life

53.91±30.65

58.60±30.40

0.534

58.27±28.20

57.35±31.22

0.898

Role limitations

25.29±33.45

28.77±31.98

0.664

33.20±37.91

26.28±30.10

0.364

Physical limitation

29.24±31.45

27.44±30.08

0.811

33.20±34.26

26.05±28.79

0.318

Social limitation

22.19±31.81

16.71±25.48

0.411

18.03±24.83

17.87±27.59

0.980

Personal relationships

21.71±37.96

25.39±32.24

0.724

24.90±35.34

24.55±32.84

0.972

Emotions

25.90±31.06

27.52±25.83

0.808

31.91±29.15

25.59±26.12

0.321

Sleep/Energy

26.08±29.49

21.02±26.64

0.454

18.67±24.13

23.28±28.22

0.475

Incontinence

14.14±27.47

9.85±14.73

0.343

16.50±21.31

8.89±16.76

0.076

Total KHQ

251.88±223.71

254.88±171.03

0.947

274.31±198.90

247.53±178.02

0.537